Starling Oncology, Inc. Fair Value, Net Asset (Liability)
Starling Oncology, Inc. (DFPH) had Fair Value, Net Asset (Liability) of $0 as of 2019-12-31, per its 10-K/A filed 2021-12-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:FairValueNetAssetLiability · last filed 2021-12-14
- 2019-12-31: Fair Value, Net Asset (Liability) $0.00.
| Period end | Fair Value, Net Asset (Liability) |
|---|---|
| 2019-12-31 | $0.00 10-K/A · filed 2021-12-14 |